A clinical trial at OHSU and UC San Francisco points the way to potential targeted therapies. The drug enzalutamide is a mainstay of treatment for men with life-threatening prostate cancer that has...
A new survey from the OHSU Knight Cancer Institute aims to help researchers understand the cancer-related needs of Oregonians and inform ways to address those needs across the state. Figure:...
Image: NCI. . For some marginalized populations in the U.S., barriers preventing access to radiation therapy and other lifesaving cancer care are as insurmountable as those in the poorest nations,...